Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 12
- Medical Cannabis
Glass Pharms Announces New UK Supply Deals as it launches Premium Range
Glass Pharms, the UK-based cultivator of medical cannabis flower, has announced a supply agreement with Integro Clinic & IPS Pharmacy to provide them with a new premium range of Glass Pharms-branded CBPMs made with domestically grown flower cultivated at the Glass Pharms facility.
- Industry Trends
In the UK’s Medical Cannabis Market, the Winner Takes All
Earlier this week, we looked at the dramatic shifts in the UK medical cannabis flower market over the last three years.
- Industry Trends
Germany’s Hidden Stigma Crisis: Why Pillar 2 is Still Sorely Needed
By: Dr. Sebastián Marincolo, Director of Strategic Content & Editorial, Weed.de Germany’s partial cannabis legalisation was originally designed to undercut the black market.
- Industry Trends
What Is Really Going on in the UK’s Medical Cannabis Market? (New 2025 Data Analysis)
The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering the most comprehensive look into what is being prescribed in the UK to date.
- Industry Trends
First Practical Medical Cannabis Oil Dosing Guide Published for UK Clinicians
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step forward for standardised prescribing in the UK, a comprehensive guide establishing evidence-based dosing protocols for cannabis oils.
- CBD Market
Medicare CBD Coverage Proposed, But Federal Ban Threatens Entire Industry
Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to authorise insurance coverage for CBD products under certain Medicare programs, even as the same products face an existential threat from recently passed federal legislation.
- Industry Trends
Kanabo Calls in Administrators, Marking Sobering End to LSE Cannabis Rush
UK medical cannabis operator Kanabo Group has fallen into administration, seeing the last remaining member of the first four cannabis pioneers onto the London Stock Exchange face collapse.
- Clinical Research
Ananda Exits Landmark NHS-Funded Epilepsy Trial and Public Markets
Ananda Pharma, one of the UK’s leading clinical-stage pharmaceutical cannabis companies, has announced a string of strategic pivots, including stepping away from a flagship UK clinical trial into epilepsy.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 2
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
- Cultivation
There’s No UK Cannabis Industry Without UK Cultivation
The UK economic growth faces a paradox of two seemingly opposing pressures, yet both may be resolved by moving in the same direction.
- Clinical Research
EU ‘Intoxicating Hemp’ Review Highlights Major Knowledge Gaps Behind Blanket Bans
Last week, the US government voted to impose a blanket ban on all so-called ‘intoxicating hemp’ substances, ending what has been a contentious and long-running battle to regulate the recent emergence of THC substitutes.
